We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+14%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.52B
AUM Growth
+$98.9M
Cap. Flow
-$39.2M
Cap. Flow %
-2.58%
Top 10 Hldgs %
25.56%
Holding
430
New
92
Increased
79
Reduced
148
Closed
77

Top Buys

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$47.1M
2
OXY icon
Occidental Petroleum
OXY
+$17.2M
3
KO icon
Coca-Cola
KO
+$9.01M
4
TXN icon
Texas Instruments
TXN
+$8.65M
5
HLLY icon
Holley
HLLY
+$7.86M

Sector Composition

Rank Sector Weight
1 Energy 22.19%
2 Financials 17.89%
3 Consumer Discretionary 14.46%
4 Industrials 11.63%
5 Technology 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICR icon
101
Vicor
VICR
$9.62B
$3.6M 0.24%
34,018
-6,236
-15% -$555K
BEAM icon
102
Beam Therapeutics
BEAM
$2.58B
$3.53M 0.23%
27,408
+7,099
+35% +$566K
IGSB icon
103
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$3.39M 0.22%
61,915
GOOGL icon
104
Alphabet (Google) Class A
GOOGL
$3.91T
$3.24M 0.21%
26,540
+1,440
+6% +$168K
BL icon
105
BlackLine
BL
$1.69B
$3.21M 0.21%
28,814
-404
-1% -$44.1K
GGPI
106
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
$3.17M 0.21%
+324,475
New +$3.18M
AMZN icon
107
Amazon
AMZN
$2.5T
$3.1M 0.2%
18,040
+4,920
+38% +$818K
ACWI icon
108
iShares MSCI ACWI ETF
ACWI
$32.6B
$3.08M 0.2%
30,488
+3,604
+13% +$359K
CUE icon
109
Cue Biopharma
CUE
$135M
$2.98M 0.2%
8,533
CTLP
110
DELISTED
Cantaloupe
CTLP
$2.96M 0.2%
+250,000
New +$2.93M
VRAY
111
DELISTED
ViewRay, Inc.
VRAY
$2.94M 0.19%
445,258
+286,203
+180% +$1.53M
CDW icon
112
CDW
CDW
$17.1B
$2.9M 0.19%
16,614
-2,559
-13% -$441K
PRTY
113
DELISTED
Party City Holdco Inc.
PRTY
$2.88M 0.19%
309,040
+130,099
+73% +$1.06M
MTW icon
114
Manitowoc
MTW
$516M
$2.84M 0.19%
+115,901
New +$2.76M
UPST icon
115
Upstart Holdings
UPST
$2.58B
$2.74M 0.18%
21,960
+14,371
+189% +$1.77M
RSP icon
116
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$2.65M 0.17%
17,563
-64,079
-78% -$9.54M
MTDR icon
117
Matador Resources
MTDR
$6.31B
$2.64M 0.17%
73,330
-64,478
-47% -$1.88M
ENVA icon
118
Enova International
ENVA
$5.91B
$2.6M 0.17%
76,136
-10,553
-12% -$372K
EOCW.U
119
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$2.53M 0.17%
+252,300
New +$2.53M
PACB icon
120
Pacific Biosciences
PACB
$422M
$2.5M 0.16%
71,363
+29,719
+71% +$864K
YTPG
121
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$2.41M 0.16%
+239,225
New +$2.42M
IESC icon
122
IES Holdings
IESC
$12.5B
$2.41M 0.16%
+46,895
New +$2.43M
CVNA icon
123
Carvana
CVNA
$43.3B
$2.38M 0.16%
39,435
+6,235
+19% +$339K
BRSL
124
Brightstar Lottery PLC
BRSL
$1.91B
$2.26M 0.15%
94,290
-823
-0.9% -$17.2K
TEN
125
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$2.24M 0.15%
+115,961
New +$1.74M

Similar funds

Advisory Research's Q2 2021 Portfolio in Review

As of Q2 2021, Advisory Research held 430 positions worth $1.52B, up 7% from $1.42B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Advisory Research's Q2 2021 filing shows 92 new, 79 increased, 148 reduced and 77 closed positions. Its largest new stake was Occidental Petroleum: 642,635 shares worth $20.1M. The largest sale was Cummins, an estimated $18.7M.

By sector, the portfolio is most concentrated in Energy at 22% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Advisory Research's largest Q2 2021 buy was Occidental Petroleum: 642,635 shares worth $20.1M.
  • Advisory Research added most to Denbury Inc. in Q2 2021, an estimated $47.1M increase.
  • Advisory Research's biggest Q2 2021 reduction was Cummins, cutting an estimated $18.7M.
  • Advisory Research fully exited Leggett & Platt in Q2 2021, selling an estimated $10.7M.
  • Advisory Research's ten largest holdings make up 26% of its $1.52B portfolio in Q2 2021.
  • Advisory Research opened 92 new positions and closed 77 in Q2 2021.
  • Advisory Research's portfolio value rose 7% quarter-over-quarter to $1.52B.

Based on Advisory Research's 13F filing for Q2 2021, filed 16 Aug 2021.